(Q37310689)

19 August 2017

1 reference

title

Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

19 August 2017

1 reference

Andrea M Chen

1

1 reference

19 August 2017

Suzanne G Bollmeier

series ordinal

2

1 reference

19 August 2017

Patrick M Finnegan

series ordinal

3

1 reference

19 August 2017

language of work or name

English

0 references

publication date

28 October 2008

1 reference

Annals of Pharmacotherapy

19 August 2017

1 reference

19 August 2017

42

1 reference

19 August 2017

1832-1842

1 reference

19 August 2017

12

1 reference

Projections of global mortality and burden of disease from 2002 to 2030

19 August 2017

1 reference

A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group

21 January 2018

1 reference

The pharmacological properties of tiotropium

21 January 2018

1 reference

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

21 January 2018

1 reference

Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis

21 January 2018

1 reference

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

Effect of salmeterol and formoterol in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action

21 January 2018

1 reference

Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV(1) reversibility

21 January 2018

1 reference

Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: results of a randomized, double-blind clinical study

21 January 2018

1 reference

Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD.

21 January 2018

1 reference

Risk versus benefit considerations for the beta(2)-agonists

21 January 2018

1 reference

Long-acting beta 2-adrenoceptor agonists or tiotropium bromide for patients with COPD: is combination therapy justified?

21 January 2018

1 reference

Observations on recent increase in mortality from asthma

21 January 2018

1 reference

Investigation into use of drugs preceding death from asthma

21 January 2018

1 reference

Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease

21 January 2018

1 reference

Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.

21 January 2018

1 reference

The functional impact of adding salmeterol and tiotropium in patients with stable COPD.

21 January 2018

1 reference

The pharmacodynamic effects of single inhaled doses of formoterol, tiotropium and their combination in patients with COPD.

21 January 2018

1 reference

A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol

21 January 2018

1 reference

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

21 January 2018

1 reference

Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD.

21 January 2018

1 reference

Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions

21 January 2018

1 reference

Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis

21 January 2018

1 reference

Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.

21 January 2018

1 reference

In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study

21 January 2018

1 reference

Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease

21 January 2018

1 reference

Inhaled therapy in elderly COPD patients; time for re-evaluation?

21 January 2018

1 reference

Treatment persistence and compliance with medications for chronic obstructive pulmonary disease

21 January 2018

1 reference

Persistence with inhaled corticosteroid therapy in daily practice

21 January 2018

1 reference

Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database

21 January 2018

1 reference

Cardiac safety profile of nebulized formoterol in adults with COPD: a 12-week, multicenter, randomized, double- blind, double-dummy, placebo- and active-controlled trial

21 January 2018

1 reference

Cardiac safety of formoterol 12 microg twice daily in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

Cost-effectiveness of long-acting bronchodilators for chronic obstructive pulmonary disease

21 January 2018

1 reference

Healthcare costs with tiotropium plus usual care versus usual care alone following 1 year of treatment in patients with chronic obstructive pulmonary disorder (COPD).

21 January 2018

1 reference

Economic evaluation of tiotropium and salmeterol in the treatment of chronic obstructive pulmonary disease (COPD) in Greece.

21 January 2018

1 reference

Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain

21 January 2018

1 reference

Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease?

21 January 2018

1 reference

Combination therapy for chronic obstructive pulmonary disease: clinical aspects

21 January 2018

1 reference

Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1L250

1 reference

19 August 2017

1 reference